Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk
The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Abstract
CONTEXT: The importance of the cholesteryl ester transfer protein (CETP) pathway in coronary disease is uncertain. Study of CETP genotypes can help better understand the relevance of this pathway to lipid metabolism and disease risk. OBJECTIVE: To assess associations of CETP genotypes with CETP phenotypes, lipid levels, and coronary risk. DATA SOURCES: Studies published between January 1970 and January 2008 were identified through computer-based and manual searches using MEDLINE, EMBASE, BIOSIS, Science Citation Index, and the Chinese National Knowledge Infrastructure Database. Previously unreported studies were sought through correspondence with investigators. STUDY SELECTION: Relevant studies related principally to 3 common (TaqIB [rs708272], I405V [rs5882], and -629C>A [rs1800775]) and 3 uncommon (D442G [rs2303790], -631C>A [rs1800776], and R451Q [rs1800777]) CETP polymorphisms. DATA EXTRACTION: Information on CETP genotypes, CETP phenotypes, lipid levels, coronary disease, and study characteristics was abstracted from publications, supplied by investigators, or both. RESULTS: Ninety-two studies had data on CETP phenotypes, lipid levels, or both in 113,833 healthy participants, and 46 studies had data on 27,196 coronary cases and 55,338 controls. For each A allele inherited, individuals with the TaqIB polymorphism had lower mean CETP mass (-9.7%; 95% confidence interval [CI], -11.7% to -7.8%), lower mean CETP activity (-8.6%; 95% CI, -13.0% to -4.1%), higher mean high-density lipoprotein cholesterol (HDL-C) concentrations (4.5%; 95% CI, 3.8%-5.2%), and higher mean apolipoprotein A-I concentrations (2.4%; 95% CI, 1.6%-3.2%). The pattern of findings was very similar with the I405V and -629C>A polymorphisms. The combined per-allele odds ratios (ORs) for coronary disease were 0.95 (95% CI, 0.92-0.99) for TaqIB, 0.94 (95% CI, 0.89-1.00) for I405V, and 0.95 (95% CI, 0.91-1.00) for -629C>A. CONCLUSIONS: Three CETP genotypes that are associated with moderate inhibition of CETP activity (and, therefore, modestly higher HDL-C levels) show weakly inverse associations with coronary risk. The ORs for coronary disease were compatible with the expected reductions in risk for equivalent increases in HDL-C concentration in available prospective studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139 · cited 2×
“angiotensin system and blood pressure elevation).(10) On the other hand, it has been suggested that HDL particles pro-”
Background(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 3×
“We supplemented published data by a tabular data request to (1) authors of published reports, (2) investigators of 75 potentially relevant unreported studies involving at least 500 coronary cases or at least 1000 healthy participants listed in published meta-analyses(21-25) of variants other than CETP, and (3) authors”
BackgroundMethodTunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Genomewide Association Analysis of Coronary Artery Disease
Samani, N. J., Erdmann, J., Hall, A. S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R. J., Meitinger, T., Braund, P., Wichmann, H.-E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072366 · Cited by 2,044
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
Willer, C. J., Sanna, S., Jackson, A. U., Scuteri, A., Bonnycastle, L. L., Clarke, R., Heath, S. C., Timpson, N. J., Najjar, S. S., Stringham, H. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.76 · Cited by 1,585
Kathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt, N. P., Rieder, M. J., Cooper, G. M., Roos, C., Voight, B. F., Havulinna, A. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.75 · Cited by 1,386 · cited 2×
“com).(17,30-165) Forty-five studies were based in Europe, 15 in North America, 29 in East Asia (predomi-”
BackgroundPopulation stratification and spurious allelic association
Cardon, L. R., & Palmer, L. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12520-2 · Cited by 1,204
Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women
Pai, J. K., Pischon, T., Ma, J., Manson, J. E., Hankinson, S. E., Joshipura, K., Curhan, G. C., Rifai, N., Cannuscio, C. C., Stampfer, M. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040967 · Cited by 1,174
Inazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., & Tall, A. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231803 · Cited by 861
Association of apolipoprotein E genotypes with lipid levels and coronary risk
Bennet, A. M., Di Angelantonio, E., Ye, Z., Wensley, F., Dahlin, A., Ahlbom, A., Keavney, B., Collins, R., Wiman, B., de Faire, U., et al. (2007) · JAMA · doi:10.1001/jama.298.11.1300 · Cited by 794
Self-citationStatins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
Nicholls, S. J., Tuzcu, E. M., Sipahi, I., Grasso, A. W., Schoenhagen, P., Hu, T., Wolski, K., Crowe, T., Desai, M. Y., Hazen, S. L., et al. (2007) · JAMA · doi:10.1001/jama.297.5.499 · Cited by 724
Prediction of the Risk of Myocardial Infarction from Polymorphisms in Candidate Genes
Yamada, Y., Izawa, H., Ichihara, S., Takatsu, F., Ishihara, H., Hirayama, H., Sone, T., Tanaka, M., & Yokota, M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021445 · Cited by 640
Zhong, S., Sharp, D. S., Grove, J. S., Bruce, C., Yano, K., Curb, J. D., & Tall, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118751 · Cited by 583
Unique Lipoprotein Phenotype and Genotype Associated With Exceptional Longevity
Barzilai, N. (2003) · JAMA · doi:10.1001/jama.290.15.2030 · Cited by 575
What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?
Smith, G. D., & Ebrahim, S. (2005) · BMJ · doi:10.1136/bmj.330.7499.1076 · Cited by 545
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
Okamoto, H., Yonemori, F., Wakitani, K., Minowa, T., Maeda, K., & Shinkai, H. (2000) · Nature · doi:10.1038/35018119 · Cited by 531
High-Density Lipoprotein as a Therapeutic Target: A Systematic Review
Singh, I. M., Shishehbor, M. H., & Ansell, B. J. (2007) · JAMA · doi:10.1001/jama.298.7.786 · Cited by 468
Bots, M. L., Visseren, F. L., Evans, G. W., Riley, W. A., Revkin, J. H., Tegeler, C. H., Shear, C. L., Duggan, W. T., Vicari, R. M., Grobbee, D. E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61088-5 · Cited by 461
Ye, Z., Liu, E. H., Higgins, J. P., Keavney, B. D., Lowe, G. D., Collins, R., & Danesh, J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68263-9 · Cited by 411
Ordovas, J. M., Cupples, L. A., Corella, D., Otvos, J. D., Osgood, D., Martinez, A., Lahoz, C., Coltell, O., Wilson, P. W. F., & Schaefer, E. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1323 · Cited by 379
Clark, R. W., Sutfin, T. A., Ruggeri, R. B., Willauer, A. T., Sugarman, E. D., Magnus-Aryitey, G., Cosgrove, P. G., Sand, T. M., Wester, R. T., Williams, J. A., et al. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000118278.21719.17 · Cited by 371
Wheeler, J. G., Keavney, B. D., Watkins, H., Collins, R., & Danesh, J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15642-0 · Cited by 317
Boekholdt, S. M., Sacks, F. M., Jukema, J. W., Shepherd, J., Freeman, D. J., McMahon, A. D., Cambien, F., Nicaud, V., de Grooth, G. J., Talmud, P. J., et al. (2005) · Circulation · doi:10.1161/01.cir.0000153341.46271.40 · Cited by 308
Lewis, S. J., Ebrahim, S., & Smith, G. D. (2005) · BMJ · doi:10.1136/bmj.38611.658947.55 · Cited by 306
Fumeron, F., Betoulle, D., Luc, G., Behague, I., Ricard, S., Poirier, O., Jemaa, R., Evans, A., Arveiler, D., & Marques-Vidal, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118207 · Cited by 301
Krishna, R., Anderson, M. S., Bergman, A. J., Jin, B., Fallon, M., Cote, J., Rosko, K., Chavez-Eng, C., Lutz, R., Bloomfield, D. M., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61813-3 · Cited by 277
Morgan, T. M., Krumholz, H. M., Lifton, R. P., & Spertus, J. A. (2007) · JAMA · doi:10.1001/jama.297.14.1551 · Cited by 270
Agerholm-Larsen, B., Nordestgaard, B. G., Steffensen, R., Jensen, G., & Tybjærg-Hansen, A. (2000) · Circulation · doi:10.1161/01.cir.101.16.1907 · Cited by 267
The Failure of Torcetrapib: Was it the Molecule or the Mechanism?
Tall, A. R., Yvan-Charvet, L., & Wang, N. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000256728.60226.77 · Cited by 267
Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review
Casas, J. P., Cavalleri, G. L., Bautista, L. E., Smeeth, L., Humphries, S. E., & Hingorani, A. D. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj302 · Cited by 236
Curb, J. D., Abbott, R. D., Rodriguez, B. L., Masaki, K., Chen, R., Sharp, D. S., & Tall, A. R. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300520-jlr200 · Cited by 228
Kuivenhoven, J. A., de Knijff, P., Boer, J. M. A., Smalheer, H. A., Botma, G.-J., Seidell, J. C., Kastelein, J. J. P., & Pritchard, P. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.3.560 · Cited by 210
Freeman, D. J., Griffin, B. A., Holmes, A. P., Lindsay, G. M., Gaffney, D., Packard, C. J., & Shepherd, J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.3.336 · Cited by 188
Kondo, I., Berg, K., Drayna, D., & Lawn, R. (1989) · Clinical Genetics · doi:10.1111/j.1399-0004.1989.tb02904.x · Cited by 178
High-Density Lipoprotein Deficiency and Dyslipoproteinemia Associated With Venous Thrombosis in Men
Deguchi, H., Pecheniuk, N. M., Elias, D. J., Averell, P. M., & Griffin, J. H. (2005) · Circulation · doi:10.1161/circulationaha.104.521344 · Cited by 173
Dachet, C., Poirier, O., Cambien, F., Chapman, J., & Rouis, M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.507 · Cited by 168
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
Boekholdt, S. M., & Thompson, J. F. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200018-jlr200 · Cited by 162
Hall, W. L., Vafeiadou, K., Hallund, J., Bügel, S., Koebnick, C., Reimann, M., Ferrari, M., Branca, F., Talbot, D. C. S., Dadd, T., et al. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.6.1260 · Cited by 159
Corbex, M. A., Poirier, O., Fumeron, F., Betoulle, D., Evans, A., Ruidavets, J. B., Arveiler, D., Luc, G., Tiret, L., & Cambien, F. (2000) · Genetic Epidemiology · doi:10.1002/1098-2272(200007)19:1<64::aid-gepi5>3.0.co;2-e · Cited by 157
Bruce, C., Sharp, D. S., & Tall, A. R. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33876-1 · Cited by 157
Fibrinogen and coronary heart disease: test of causality by ‘Mendelian randomization’
Keavney, B. D., Danesh, J., Parish, S., Palmer, A., Clark, S., Youngman, L. D., Délepine, M., Lathrop, M. G., Peto, R., & Collins, R. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl114 · Cited by 150
Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study
Tobin, M. D. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.11.014 · Cited by 143
Hannuksela, M. L., Liinamaa, J., Kesäniemi, Y. A., & Savolainen, M. J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90065-5 · Cited by 143
Hall, W. L., Vafeiadou, K., Hallund, J., Bügel, S., Reimann, M., Koebnick, C., Zunft, H.-J. F., Ferrari, M., Branca, F., Dadd, T., et al. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.83.3.592 · Cited by 141
Gudnason, V. G., Kakko, S., Nicaud, V., Savolainen, M. J., Kesäniemi, Y. A., Tahvanainen, E., Humphries, S. E., & On Behalf Of The Ears Group (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00412.x · Cited by 139
Agerholm-Larsen, B., Tybjærg‐Hansen, A., Schnohr, P., Steffensen, R., & Nordestgaard, B. G. (2000) · Circulation · doi:10.1161/01.cir.102.18.2197 · Cited by 130
Borggreve, S. E., Hillege, H. L., Wolffenbuttel, B. H. R., de Jong, P. E., Zuurman, M. W., van der Steege, G., van Tol, A., & Dullaart, R. P. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2322 · Cited by 129
CETP Inhibitors to Increase HDL Cholesterol Levels
Tall, A. R. (2007) · New England Journal of Medicine · doi:10.1056/nejme078029 · Cited by 128
Illuminating HDL — Is It Still a Viable Therapeutic Target?
Rader, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejme0707210 · Cited by 119
Buffering Mechanisms in Aging: A Systems Approach Toward Uncovering the Genetic Component of Aging
Bergman, A., Atzmon, G., Ye, K. Q., MacCarthy, T., & Barzilai, N. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030170 · Cited by 117
Freeman, D. J. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.07.001 · Cited by 114
A genotype of exceptional longevity is associated with preservation of cognitive function
Barzilai, N., Atzmon, G., Derby, C. A., Bauman, J., & Lipton, R. B. (2006) · Neurology · doi:10.1212/01.wnl.0000249116.50854.65 · Cited by 112
Carr, M. C., Ayyobi, A. F., Murdoch, S. J., Deeb, S. S., & Brunzell, J. D. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000013284.47317.95 · Cited by 106
Kauma, H., Savolainen, M. J., Heikkilä, R., Rantala, A. O., Lilja, M., Reunanen, A., & Kesäniemi, Y. A. (1996) · Human Genetics · doi:10.1007/bf02265258 · Cited by 98
Zee, R. Y. L., Cook, N. R., Cheng, S., Reynolds, R., Erlich, H. A., Lindpaintner, K., & Ridker, P. M. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh039 · Cited by 98
Corella, D., Sáiz, C., Guillén, M., Portolés, O., Mulet, F., González, J. I., & Ordovás, J. M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00477-3 · Cited by 96
Jang, Y., Kim, J. Y., Kim, O. Y., Lee, J. E., Cho, H., Ordovás, J. M., & Lee, J. H. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.4.832 · Cited by 96
Hinds, D. A., Seymour, A. B., Durham, L. K., Banerjee, P., Ballinger, D. G., Milos, P. M., Cox, D., Thompson, J. F., & Frazer, K. A. (2004) · Human Genomics · doi:10.1186/1479-7364-1-6-421 · Cited by 89
Liu, S., Schmitz, C., Stampfer, M. J., Sacks, F. M., Hennekens, C. H., Lindpaintner, K., & Ridker, P. M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00673-6 · Cited by 88
Juvonen, T. S., Savolainen, M. J., Kairaluoma, M. I., Lajunen, L. H. J., Humphries, S. E., & Kesäniemi, Y. A. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40064-1 · Cited by 86
Talmud, P. J., Hawe, E., ROBERTSON, K., Miller, G. J., MILLER, N. E., & Humphries, S. E. (2002) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2002.00105.x · Cited by 78
Martinelli, N., Trabetti, E., Bassi, A., Girelli, D., Friso, S., Pizzolo, F., Sandri, M. F., Malerba, G., Pignatti, P. F., Corrocher, R., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.009 · Cited by 72
Polymorphisms in the CETP gene and association with CETP mass and HDL levels
Thompson, J. F., Lira, M. E., Durham, L. K., Clark, R. W., Bamberger, M. J., & Milos, P. M. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00005-4 · Cited by 72
Borggreve, S. E., Hillege, H. L., Wolffenbuttel, B. H. R., de Jong, P. E., Bakker, S. J. L., van der Steege, G., van Tol, A., & Dullaart, R. P. F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0182 · Cited by 72
Nettleton, J. A., Steffen, L. M., Ballantyne, C. M., Boerwinkle, E., & Folsom, A. R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.025 · Cited by 69
Kakko, Tamminen, Päivänsalo, Kauma, Rantala, Lilja, Reunanen, Kesäniemi, & Savolainen (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00595.x · Cited by 65
Eiríksdóttir, G., Bolla, M. K., Thorsson, B., Sigurðsson, G., Humphries, S. E., & Gudnason, V. G. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00489-0 · Cited by 63
Keavney, B. D., Palmer, A., Parish, S., Clark, S., Youngman, L., Danesh, J., McKenzie, C., Delépine, M., Lathrop, M., Peto, R., et al. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh275 · Cited by 62
Ruiz-Narváez, E., Yang, Y., Nakanishi, Y., Kirchdorfer, J., & Campos, H. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500040-jlr200 · Cited by 61
Tenkanen, H., Koskinen, P., KONTULA, K. K., Aalto‐Setälä, K., M�ntt�ri, M., Manninen, V., Runeberg, S.-L., Taskinen, M., & Ehnholm, C. (1991) · Human Genetics · doi:10.1007/bf00209015 · Cited by 61
Hsu, L., Ko, Y., Hsu, K., Ko, Y.-H., & Lee, Y. (2001) · Human Genetics · doi:10.1007/s00439-001-0640-z · Cited by 60
Kakko, S., Tamminen, M., Päivänsalo, M. J., Kauma, H., Rantala, A. O., Lilja, M., Reunanen, A., Kesäniemi, Y. A., & Savolainen, M. J. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00859.x · Cited by 59
van Acker, B. A. C., Botma, G.-J., Zwinderman, A. H., Kuivenhoven, J. A., Dallinga‐Thie, G. M., Sijbrands, E. J. G., Boer, J. M. A., Seidell, J. C., Jukema, J. W., Kastelein, J. J. P., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.019 · Cited by 59
Vohl, M.-C., Lamarche, B., Pascot, A., Leroux, G., Prud’homme, D., Bouchard, C., Nadeau, A., & Després, J. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800972 · Cited by 58
Zee, R. Y. L., Cook, N. R., Cheng, S., ERLICH, H. A., Lindpaintner, K., & Ridker, P. M. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01754.x · Cited by 58
Plat, J., & Mensink, R. P. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00982.x · Cited by 57
CETP inhibition in cardiovascular risk management: a critical appraisal
Dullaart, R. P. F., Dallinga‐Thie, G. M., Wolffenbuttel, B. H. R., & van Tol, A. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01756.x · Cited by 57
Kark, J. D., Sinnreich, R., Leitersdorf, E., Friedlander, Y., Shpitzen, S., & Luc, G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00408-6 · Cited by 57
Klos, K. L. E., Sing, C. F., Boerwinkle, E., Hamon, S., Rea, T. J., Clark, A. G., Fornage, M., & Hixson, J. E. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000231523.19199.45 · Cited by 54
Goto, A., Sasai, K., Suzuki, S., Fukutomi, T., Ito, S., Matsushita, T., Okamoto, M., Suzuki, T., Itoh, M., Okumura‐Noji, K., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00476-2 · Cited by 52
Thompson, J. F., Durham, L. K., Lira, M. E., Shear, C. L., & Milos, P. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.01.015 · Cited by 52
Tai, E. S., Ordovás, J. M., Corella, D., Deurenberg‐Yap, M., Chan, E., Adiconis, X., Chew, S. K., Loh, L., & Tan, C. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.630104.x · Cited by 50
Wu, J. H., Lee, Y., Hsu, H., & Hsieh, L.-L. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00524-x · Cited by 50
Heidema, A. G., Feskens, E. J. M., Doevendans, P. A., Ruven, H. J. T., van Houwelingen, H. C., Mariman, E. C. M., & Boer, J. M. A. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20251 · Cited by 49
Friedlander, Y., Leitersdorf, E., Vecsler, R., Funke, H., & Kark, J. D. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00474-8 · Cited by 49
Riemens, S. C., van Tol, A., Stulp, B. K., & Dullaart, R. P. F. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33389-7 · Cited by 47
Whiting, B. M., Anderson, J. L., Muhlestein, J. B., Horne, B. D., Bair, T. L., Pearson, R. R., & Carlquist, J. F. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.08.034 · Cited by 44
Arai, Y., Hirose, N., Yamamura, K., Nakazawa, S., Shimizu, K.-I., Takayama, M., Ebihara, Y., Homma, S., Gondo, Y., Masui, Y., et al. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0407-6 · Cited by 43
Mendis, S., Shepherd, J., Packard, C. J., & Gaffney, D. F. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90126-4 · Cited by 42
Arca, M., Montali, A., Ombres, D., Battiloro, E., Campagna, F., Ricci, G., & Verna, R. (2001) · Clinical Genetics · doi:10.1034/j.1399-0004.2001.600510.x · Cited by 41
Arai, H., Yamamoto, A., Matsuzawa, Y., Saitō, Y., Yamada, N., Oikawa, S., Mabuchi, H., Teramoto, T., Sasaki, J., Nakaya, N., et al. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.240 · Cited by 41
Asselbergs, F. W., Moore, J. H., van den Berg, M. P., Rimm, E. B., de Boer, R. A., Dullaart, R. P. F., Navis, G. J., & van Gilst, W. H. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-39 · Cited by 41
The Taq1B‐variant in the Cholesteryl Ester–Transfer Protein Gene and the Risk of Metabolic Syndrome
Sandhofer, A., Tatarczyk, T., Laimer, M. W., Ritsch, A., Kaser, S., Paulweber, B., Ebenbichler, C. F., & Patsch, J. R. (2008) · Obesity · doi:10.1038/oby.2007.130 · Cited by 40
McCaskie, P. A., Beilby, J. P., Chapman, C., Hung, J., McQuillan, B., Thompson, P. L., & Palmer, L. J. (2007) · Human Genetics · doi:10.1007/s00439-007-0326-2 · Cited by 38
Sorlí, J. V., Corella, D., Francès, F., Sabio, J. B. R., González, J. I., Guillén, M., & Portolés, O. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.10.001 · Cited by 38
Akita, H., Chiba, H., Tsuchihashi, K., Tsuji, M., Kumagai, M., Matsuno, K., & Kobayashi, K. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1615 · Cited by 37
Yılmaz, H., sbir, T., Ağaçhan, B., & Karaali, Z. (2004) · Cell Biochemistry and Function · doi:10.1002/cbf.1124 · Cited by 37
Gudnason, V. G., Þormar, K., & Humphries, S. E. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02407.x · Cited by 36
High-density genotyping and functional SNP localization in the CETP gene
Thompson, J. F., Wood, L. S., Pickering, E. H., DeChairo, B. M., & Hyde, C. L. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600372-jlr200 · Cited by 36
Tsujita, Y., Nakamura, Y., Zhang, Q., Tamaki, S., Nozaki, A., Amamoto, K., Kadowaki, T., Kita, Y., Okamura, T., Horie, M., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.028 · Cited by 32
Kakko, S., Tamminen, M., Kesäniemi, Y. A., & Savolainen, M. J. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00201-3 · Cited by 31
Vergani, C., Lucchi, T. A., Caloni, M., Ceconi, I., Calabresi, C., Scurati, S., & Arosio, B. (2005) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2005.10.008 · Cited by 31
Ikewaki, K., Mabuchi, H., Teramoto, T., Yamada, N., Oikawa, S., Sasaki, J., Takata, K., & Saitō, Y. (2003) · Metabolism · doi:10.1016/j.metabol.2003.07.011 · Cited by 31
Inazu, A., Nishimura, Y., Terada, Y., & Mabuchi, H. (2001) · Journal of Human Genetics · doi:10.1007/s100380170084 · Cited by 30
Lloyd, D. B., Lira, M. E., Wood, L. S., Durham, L. K., Freeman, T. B., Preston, G. M., Qiu, X., Sugarman, E. D., Bonnette, P. C., Lanzetti, A. J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500523200 · Cited by 30
Prevalence of genetic risk factors for coronary artery disease in Corsica island (France)
Falchi, A., Giovannoni, L., Piras, I. S., Calò, C. M., Moral, P., Vona, G., & Varesi, L. (2005) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.09.005 · Cited by 29
Noone, E., Roche, H. M., Black, I. L., Tully, A.-M., & Gibney, M. J. (2000) · British Journal Of Nutrition · doi:10.1017/s0007114500001434 · Cited by 28
Isaacs, A. J., Aulchenko, Y. S., Albert Hofman, D., Sijbrands, E. J. G., Sayed‐Tabatabaei, F. A., Klungel, O. H., der Zee, A. H. M., Stricker, B. H. C., Oostra, B. A., Witteman, J. C. M., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0269 · Cited by 28
İşbir, T., Yılmaz, H., Ağaçhan, B., & Karaali, Z. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00137.x · Cited by 27
Okumura, K., Matsui, H., Kamiya, H., Saburi, Y., Hayashi, K., & Hayakawa, T. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00653-0 · Cited by 26
Isaacs, A., Sayed‐Tabatabaei, F. A., Hofman, A., et al. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32801101aa · Cited by 24
Elosúa, R., Cupples, L. A., Fox, C. S., Polak, J. F., D’Agostino, R. B., Wolf, P. A., O’Donnell, C. J., & Ordovás, J. M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.005 · Cited by 23
Thompson, J. F., Lloyd, D. B., Lira, M., & Milos, P. (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00289.x · Cited by 20
Hodoğlugil, U., Williamson, D., Huang, Y., & Mahley, R. W. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00467.x · Cited by 20
Mukherjee, M., & Shetty, K. (2004) · Clinical Genetics · doi:10.1111/j.0009-9163.2004.0237.x · Cited by 20
Dedoussis, G. V., Panagiotakos, D. B., Louizou, E., Mantoglou, I., Chrysohoou, C. A., Lamnissou, K., Pitsavos, C. E., & Stefanadis, C. (2007) · Human Heredity · doi:10.1159/000099827 · Cited by 20
Tamminen, M., Kakko, S., Kesäniemi, Y. A., & Savolainen, M. J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05833-9 · Cited by 20
Horne, B. D., Camp, N. J., Anderson, J. L., Mower, C. P., Clarke, J., Kolek, M. J., & Carlquist, J. F. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.039 · Cited by 19
No Physical Activity ?? CETP 1b.-629 Interaction Effects on Lipid Profile
Bernstein, M., Costanza, M. C., James, R. W., Morris, M. A., Cambien, F., RAOUX, S., & Morabia, A. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000074444.27594.b0 · Cited by 19
Parental history of myocardial infarction: lipid traits, gene polymorphisms and lifestyle
Boer, J. M. A., Feskens, E. J. M., Kuivenhoven, J. A., Schouten, E. G., Havekes, L. M., Kastelein, J. J. P., Seidell, J. C., & Kromhout, D. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00521-9 · Cited by 19
Zheng, K.-Q., Zhang, S., He, Y., Zhang, L., Zhang, K., Huang, D., & Sun, Y. (2004) · PubMed · Cited by 19
Chen, J., Yokoyama, T., Saito, K., Yoshiike, N., Date, C., & Tanaka, H. (2002) · Journal of Epidemiology · doi:10.2188/jea.12.77 · Cited by 18
Weitgasser, R., Galvan, G., Malaimare, L., Derflinger, I., Hedegger, M., Lang, J., Iglseder, B., Ladurner, G., & Paulweber, B. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.09.010 · Cited by 18
Zheng, K.-Q., Zhang, S., Zhang, L., He, Y., Liao, L., Hou, Y., & Huang, D. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.08.065 · Cited by 17
Volcik, K. A., Ballantyne, C. M., Pownall, H. J., Sharrett, A. R., & Boerwinkle, E. (2007) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2007.68.485 · Cited by 17
HIGH DENSITY LIPOPROTEIN: GUARDIAN OF THE VASCULAR SYSTEM?
Packard, C. J., Nunn, A. V. W., Hobbs, R. F., & members of the Future Forum Editorial Board* (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11373.x · Cited by 16
Al‐Daghri, N. M., Al-Attas, O., Patel, A., Belyaev, N. D., Bartlett, W. A., Jones, A. F., Kumar, S., & Bain, S. C. (2003) · Clinical Science · doi:10.1042/cs20030007 · Cited by 14
Blankenberg, S., Tiret, L., Bickel, C., Schlitt, A., Jungmair, W., Genth‐Zotz, S., Lubos, E., Espinola-Klein, C., & Rupprecht, H.-J. (2004) · Zeitschrift für Kardiologie · doi:10.1007/s00392-004-1404-2 · Cited by 14
Bauerfeind, A., Knoblauch, H., Schuster, H., Luft, F. C., & Jg, R. (2002) · Human Heredity · doi:10.1159/000070662 · Cited by 13
HDL cholesterol and atherosclerosis
Mazzone, T. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61063-0 · Cited by 13
Horne, B. D., Carlquist, J. F., Cannon‐Albright, L., Muhlestein, J. B., McKinney, J. T., Kolek, M. J., Clarke, J., Anderson, J. L., & Camp, N. J. (2006) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2005.00244.x · Cited by 12
Dullaart, R. P. F., Borggreve, S. E., Hillege, H. L., & Dallinga‐Thie, G. M. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701519719 · Cited by 11
Highly polymorphic repeat region in the CETP promoter induces unusual DNA structure
Lira, M. E., Lloyd, D. B., Hallowell, S., Milos, P. M., & Thompson, J. F. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.06.002 · Cited by 11
Genetic Variations of Cholesterol Ester Transfer Protein Gene in Koreans
Hong, S. H., Kim, Y. R., Song, J., & Kim, J. Q. (2001) · Human Biology · doi:10.1353/hub.2001.0083 · Cited by 9
Motohashi, Y., Maruyama, T., Murata, M., Nakano, S., Maruyama, C., Kyotani, S., Tsushima, M., & Saruta, T. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80041-3 · Cited by 9
A triumvirate of targets in the prevention and treatment paradigm for cardiovascular disease
Packard, C. J. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.01.004 · Cited by 8
Lucchi, T. A., Arosio, B., Caloni, M., Ceconi, I., Calabresi, C., Scurati, S., & Vergani, C. (2005) · PubMed · Cited by 8
Wang, W., Zhou, X., Liu, F., et al. (2004) · Zhonghua xinxueguanbing zazhi · Cited by 6
鄢盛恺, 朱燕林, 程澍, et al. (2004) · Zhonghua jianyan yixue zazhi · doi:10.3760/j:issn:1009-9158.2004.10.016 · Cited by 5
Liu, S., Schmitz, C., Stampfer, M. J., et al. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00108-9 · Cited by 3
Cited by
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Effects of dalcetrapib in patients with a recent acute coronary syndrome
Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., Chaitman, B. R., Holme, I. M., Kallend, D., Leiter, L. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206797 · Cited by 2,022
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Evacetrapib and cardiovascular outcomes in high-risk vascular disease
Lincoff, A. M., Nicholls, S. J., Riesmeyer, J. S., Barter, P. J., Brewer, H. B., Fox, K. A. A., Gibson, C. M., Granger, C., Menon, V., Montalescot, G., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609581 · Cited by 801
Safety of anacetrapib in patients with or at high risk for coronary heart disease
Cannon, C. P., Shah, S., Dansky, H. M., Davidson, M., Brinton, E. A., Gotto, A. M., Stepanavage, M., Liu, S. X., Gibbons, P., Ashraf, T. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1009744 · Cited by 749
Metadata
- Authors
- Thompson, A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-06-18
- Volume
- 299
- Issue
- 23
- Pages
- 2777
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2134811220
- Cited by
- 497
- References
- 143
- FWCI
- 28.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.